Proton Therapy, Outcomes and Cost

Proton therapy is a type of external beam radiotherapy that uses a beam of protons to eradicate aberrant tissues and cells such as those found in cancerous tumors.

Open Forum: When is Prostate Cancer Really Prostate Cancer? - Part II

This year a task force, working at the behest of the U.S. government, issued a D grade, for “don’t recommend” against the routine use of the prostate specific antigen (PSA) test to screen for prostate cancer in men.

New Milestone in Monitoring Men’s Real-Time Responses to Treatment at the Cancer Cellular Level—Detecting AR Signaling in Circulating Tumor Cells

Technology now allows the capture of prostate cancer cells in the bloodstream once they have migrated from the primary cancer site in the prostate gland. This technology has recently become so sensitive it can detect and capture a single migratory cancer cell out of a blood pool of some 20 million blood cells.

Engineering a Wonder Weed

Can a toxic weed be engineered into a prodrug that can wipe out cancer?

Open Forum: When is Prostate Cancer Really Prostate Cancer?

This year a task force, working at the behest of the U.S. government, issued a D grade, for “don’t recommend” against the routine use of the prostate specific antigen (PSA) test to screen for prostate cancer in men.

African Americans: At Higher Risk for Prostate Cancer

Of the more than 242,000 American men who will be diagnosed with prostate cancer and the 28,000 who will die as a result of it this year, a disproportionate number of African-American men will be represented in each group.

Saying He's 'Finished' With Prostate Cancer Treatment, Gov. Jerry Brown Pronounces Himself 'Rarin' to Go'

Gov. Jerry Brown said Tuesday he's "finished" with his treatments for prostate cancer and pronounced himself fit for the rough haul ahead, which includes rolling out the state budget Thursday.

Study Finds Active Surveillance Safe and Effective for Monitoring Low-Risk Prostate Cancer Patients; Recommends Restaging Biopsy Prior to Enrollment

Active Surveillance is a monitoring program employed for patients diagnosed with low-risk prostate cancer. Because a large percentage of men diagnosed with prostate cancer have disease characteristics indicative of low-risk for cancer progression to lethal stages, active surveillance is gaining popularity as a means to avoid overtreatment of indolent slow-growing prostate cancers.

New Center for Prostate Cancer to be led by PCF Researcher Dr. Ashutosh Tewari

Researcher, mentor and long-time friend to PCF, Dr. Ashutosh Tewari will lead the new Center for Prostate Cancer at New York-Presbyterian/Weill Cornell Medical Center.

The Partin Tables Used to Predict Cancer Stage at Prostatectomy Updated

The Partin Tables—created by PCF-funded researcher Dr. Alan Partin, director of Urology at the Johns Hopkins University School of Medicine—is a statistical modeling tool that uses pre-surgical data, such as PSA levels, biopsy and clinical findings, to predict the stage of cancer spread at the time of prostatectomy.

Prostate Cancer: What Did We Learn From the 2012 Annual Scientific Meeting of ASCO?

In recent years, management of prostate cancer has benefited from an expanding array of new pharmacological options that are the result, in part, of an increased understanding of, and ability to target, androgen signaling.

Epigenetics and Cancer

Understanding how epigenetic changes to genes—changes that don’t affect the underlying DNA of a gene, but rather, if that gene is turned “on” or “off”—is a major field of cancer research.

Famed New York Philanthropist Commits $7 Million to Advanced Prostate Cancer Research

Generous Commitments from Stewart Rahr to Support PCF-Stand Up To Cancer Dream Team and Research Programs Sponsored by PCF

First-Ever National Proactive Surveillance Network Launches as Resource for Men Diagnosed with Early Stage Prostate Cancer

Web-Based Program Created to Reduce Overtreatment for Low-Grade, Indolent Prostate Cancers

Stand Up To Cancer and Prostate Cancer Foundation Announce Second Research “Dream Team”

Up to $10 Million Grant Over Three Years will Fund Cutting-edge, Collaborative Research to Develop Personalized Treatments for Advanced Prostate Cancer

Prostate Cancer Awareness Week Kicks-Off in Santa Monica

Local Retailer, Hotels and Landmarks Turn Blue for Prostate Cancer to Prompt Conversations That Could Save Lives

Prostate Cancer Takes Center Stage in Downtown Denver with Sports Authority Rock ‘n’ Roll Marathon & ½

Marathon Expected to Draw Thousands of Participants on September 22, 2012

Prostate Cancer Foundation Featured in AACR Cancer Progress Report 2012

Report Calls for Medical Research to Become a National Priority